FDA’s Fall Agenda

Life Sciences Webinar

October 14, 2026 | 12:00 PM ET

Federal fiscal year 2027 is underway as of Oct. 1, but calendar year 2026 still has a few must-do’s for the FDA and life sciences regulatory professionals. The agency’s commitment letters for the upcoming user fee reauthorizations are out and pending transmission to the Hill – but regular policy work continues as the agency advance several high-priority work streams. With new leadership on the horizon, and a new structure for the agency under Simple Reform, AgencyIQ will walk through what regulatory professionals need to know as we race to the end of the year.